AEON

AEON Biopharma, Inc. AEON

NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 22 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$9.22M total
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/AEON

Earnings Per Share

13fpro.ai/company/AEON

Loading ratio trend…

AEON insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About AEON Biopharma, Inc. (AEON): stock profile, AI score and financials

AEON Biopharma, Inc. (AEON) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. AEON is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 22 institutional filers currently hold this stock. Top institutional holders of AEON by reported 13-F value include Dauntless Investment Group, GEODE CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. AEON trades on the NYSE exchange and files with the SEC under CIK 1837607. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AEON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AEON Biopharma, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1837607 →